Fusion Antibodies – trading update, cash sufficient for “current requirements”?...
By Steve Moore | Friday 6 May 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Fusion Antibodies (FAB) has announced a trading update for its year ended 31st March 2022 and that “the number of customer enquiries being received for all of the company's services remains strong, and in H2 of FY2022 the company strengthened its commercial team”. So what of a current 67p share price?...
You must be a registered member to read this story
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.